Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

DarioHealth (DRIO) Net Margin (2016 - 2025)

DarioHealth filings provide 12 years of Net Margin readings, the most recent being 142.53% for Q4 2025.

  • On a quarterly basis, Net Margin fell 2151.0% to 142.53% in Q4 2025 year-over-year; TTM through Dec 2025 was 215.74%, a 11778.0% decrease, with the full-year FY2025 number at 196.91%, down 13682.0% from a year prior.
  • Net Margin hit 142.53% in Q4 2025 for DarioHealth, up from 376.57% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 222.21% in Q4 2023 to a low of 480.5% in Q3 2023.
  • Median Net Margin over the past 5 years was 219.2% (2022), compared with a mean of 204.78%.
  • Biggest five-year swings in Net Margin: surged 40670bps in 2022 and later crashed -25235bps in 2023.
  • DarioHealth's Net Margin stood at 317.92% in 2021, then soared by 128bps to 88.79% in 2022, then skyrocketed by 150bps to 222.21% in 2023, then dropped by -26bps to 164.05% in 2024, then decreased by -13bps to 142.53% in 2025.
  • The last three reported values for Net Margin were 142.53% (Q4 2025), 376.57% (Q3 2025), and 424.57% (Q2 2025) per Business Quant data.